{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T06:11:57Z","timestamp":1793772717432,"version":"4.6.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["17pc0101018h0001"],"award-info":[{"award-number":["17pc0101018h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.neuropharm.2023.109511","type":"journal-article","created":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T04:35:06Z","timestamp":1680150906000},"page":"109511","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["KNT-127, a selective delta opioid receptor agonist, shows beneficial effects in the hippocampal dentate gyrus of a chronic vicarious social defeat stress mouse model"],"prefix":"10.1016","volume":"232","author":[{"given":"Toshinori","family":"Yoshioka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eri","family":"Segi-Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Nagase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8617-2441","authenticated-orcid":false,"given":"Akiyoshi","family":"Saitoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2023.109511_bib1","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1038\/npp.2009.75","article-title":"Antidepressants increase neural progenitor cells in the human hippocampus","volume":"34","author":"Boldrini","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2023.109511_bib2","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s00213-016-4218-9","article-title":"Stress and neuroinflammation: a systematic review of the effects of stress on microglia and the implications for mental illness","volume":"233","author":"Calcia","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2023.109511_bib3","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00221-020-05983-9","article-title":"\u03b4-Opioid receptor activation ameliorates lipopolysaccharide-induced inflammation and apoptosis by inhibiting the MAPK\/caspase-3 pathway in BV2 microglial cells","volume":"239","author":"Cheng","year":"2021","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.neuropharm.2023.109511_bib4","doi-asserted-by":"crossref","first-page":"E370","DOI":"10.1097\/HTR.0000000000000754","article-title":"The role of neuroinflammation in neuropsychiatric disorders following traumatic brain injury: a systematic review","volume":"37","author":"Feiger","year":"2022","journal-title":"J. Head Trauma Rehabil."},{"key":"10.1016\/j.neuropharm.2023.109511_bib5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/76061","article-title":"Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses","volume":"25","author":"Filliol","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2023.109511_bib6","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/10253890.2018.1470238","article-title":"Role of glucocorticoid negative feedback in the regulation of HPA axis pulsatility","volume":"21","author":"Gjerstad","year":"2018","journal-title":"Stress"},{"key":"10.1016\/j.neuropharm.2023.109511_bib7","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nprot0415-644a","article-title":"Corrigendum: a standardized protocol for repeated social defeat stress in mice","volume":"10","author":"Golden","year":"2015","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neuropharm.2023.109511_bib8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bbr.2016.11.008","article-title":"Effects of repeated treatment with a delta opioid receptor agonist KNT-127 on hyperemotionality in olfactory-bulbectomized rats","volume":"323","author":"Gotoh","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2023.109511_bib9","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1146\/annurev.clinpsy.1.102803.143938","article-title":"Stress and depression","volume":"1","author":"Hammen","year":"2005","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"10.1016\/j.neuropharm.2023.109511_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-clinpsy-050817-084811","article-title":"Risk factors for depression: an autobiographical review","volume":"14","author":"Hammen","year":"2018","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"10.1016\/j.neuropharm.2023.109511_bib11","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/j.2040-4603.2016.tb00694.x","article-title":"Regulation of the hypothalamic-pituitary-adrenocortical stress response","volume":"6","author":"Herman","year":"2016","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.neuropharm.2023.109511_bib12","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1080\/10253890.2020.1859475","article-title":"Brain mechanisms of HPA axis regulation: neurocircuitry and feedback in context Richard Kvetnansky lecture","volume":"23","author":"Herman","year":"2020","journal-title":"Stress"},{"key":"10.1016\/j.neuropharm.2023.109511_bib13","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0893-133X(00)00159-7","article-title":"The corticosteroid receptor hypothesis of depression","volume":"23","author":"Holsboer","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2023.109511_bib14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13041-015-0120-3","article-title":"Role of the 5-HT4 receptor in chronic fluoxetine treatment-induced neurogenic activity and granule cell dematuration in the dentate gyrus","volume":"8","author":"Imoto","year":"2015","journal-title":"Mol. Brain"},{"key":"10.1016\/j.neuropharm.2023.109511_bib15","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/sj.mp.4000712","article-title":"Adult brain neurogenesis and psychiatry: a novel theory of depression","volume":"5","author":"Jacobs","year":"2000","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2023.109511_bib16","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/nyas.13217","article-title":"Cortisol dysregulation: the bidirectional link between stress, depression, and type 2 diabetes mellitus","volume":"1391","author":"Joseph","year":"2017","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2023.109511_bib17","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0006-3223(03)00319-6","article-title":"Depressed new neurons-adult hippocampal neurogenesis and a cellular plasticity hypothesis of major depression","volume":"54","author":"Kempermann","year":"2003","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2023.109511_bib18","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1177\/0269881117711708","article-title":"Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard antidepressant therapy","volume":"31","author":"Kopschina Feltes","year":"2017","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2023.109511_bib19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.yfrne.2018.02.001","article-title":"The effects of chronic stress on the human brain: from neurotoxicity, to vulnerability, to opportunity","volume":"49","author":"Lupien","year":"2018","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.neuropharm.2023.109511_bib20","doi-asserted-by":"crossref","first-page":"6302","DOI":"10.1016\/j.bmcl.2010.08.083","article-title":"Design and synthesis of KNT-127, a \u03b4-opioid receptor agonist effective by systemic administration","volume":"20","author":"Nagase","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.neuropharm.2023.109511_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2019.107427","article-title":"Research and development of \u03ba opioid receptor agonists and \u03b4 opioid receptor agonists","volume":"205","author":"Nagase","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2023.109511_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.730706","article-title":"Delta opioid receptor agonists ameliorate colonic inflammation by modulating immune responses","volume":"12","author":"Nagata","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2023.109511_bib23","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1046\/j.1365-2826.2003.01058.x","article-title":"Depression, stress and the adrenal axis","volume":"15","author":"Pariante","year":"2003","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.neuropharm.2023.109511_bib24","article-title":"The ARRIVE guidelines 2.0: updated guidelines for reporting animal research","volume":"18","author":"Percie du Sert","year":"2020","journal-title":"PLoS Biol."},{"key":"10.1016\/j.neuropharm.2023.109511_bib25","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.tips.2011.06.008","article-title":"The delta opioid receptor: an evolving target for the treatment of brain disorders","volume":"32","author":"Pradhan","year":"2011","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2023.109511_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci11050658","article-title":"The participation of microglia in neurogenesis: a review","volume":"11","author":"P\u00e9rez-Rodr\u00edguez","year":"2021","journal-title":"Brain Sci."},{"key":"10.1016\/j.neuropharm.2023.109511_bib27","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s00213-015-4195-4","article-title":"A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression","volume":"233","author":"Richards","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2023.109511_bib28","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1254\/jphs.FPJ04014X","article-title":"Potential anxiolytic and antidepressant-like activities of SNC80, a selective delta-opioid agonist, in behavioral models in rodents","volume":"95","author":"Saitoh","year":"2004","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2023.109511_bib29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/164_2016_18","article-title":"Delta opioid receptor (DOR) ligands and pharmacology: development of indolo- and quinolinomorphinan derivatives based on the message-address concept","volume":"247","author":"Saitoh","year":"2018","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.neuropharm.2023.109511_bib30","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.bbr.2011.04.041","article-title":"The novel \u03b4 opioid receptor agonist KNT-127 produces antidepressant-like and antinociceptive effects in mice without producing convulsions","volume":"223","author":"Saitoh","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2023.109511_bib31","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.neuropharm.2012.11.025","article-title":"The novel \u03b4 opioid receptor agonist KNT-127 produces distinct anxiolytic-like effects in rats without producing the adverse effects associated with benzodiazepines","volume":"67","author":"Saitoh","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2023.109511_bib32","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2174\/157015912803217314","article-title":"Antidepressant-like effects of \u03b4 opioid receptor agonists in animal models","volume":"10","author":"Saitoh","year":"2012","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2023.109511_bib33","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00213-005-0112-6","article-title":"Role of delta-opioid receptor subtypes in anxiety-related behaviors in the elevated plus-maze in rats","volume":"182","author":"Saitoh","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2023.109511_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2021.147297","article-title":"A selective delta opioid receptor agonist SNC80, but not KNT-127, induced tremor-like behaviors via hippocampal glutamatergic system in mice","volume":"1757","author":"Sakamoto","year":"2021","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2023.109511_bib35","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.1083328","article-title":"Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants","volume":"301","author":"Santarelli","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2023.109511_bib36","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jneumeth.2015.10.012","article-title":"Vicarious social defeat stress: bridging the gap between physical and emotional stress","volume":"258","author":"Sial","year":"2016","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2023.109511_bib37","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/nature10287","article-title":"Adult hippocampal neurogenesis buffers stress responses and depressive behaviour","volume":"476","author":"Snyder","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2023.109511_bib38","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.biopsych.2012.06.006","article-title":"Neurobiological sequelae of witnessing stressful events in adult mice","volume":"73","author":"Warren","year":"2013","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2023.109511_bib45","author":"World Health Organization"},{"key":"10.1016\/j.neuropharm.2023.109511_bib39","doi-asserted-by":"crossref","first-page":"494","DOI":"10.2174\/1570159X1304150831150507","article-title":"The effects of psychological stress on depression","volume":"13","author":"Yang","year":"2015","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2023.109511_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.993132","article-title":"Repeated psychological stress, chronic vicarious social defeat stress, evokes irritable bowel syndrome-like symptoms in mice","volume":"16","author":"Yoshioka","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109511_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2021.113536","article-title":"Chronic vicarious social defeat stress attenuates new-born neuronal cell survival in mouse hippocampus","volume":"416","author":"Yoshioka","year":"2022","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2023.109511_bib42","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1002\/glia.23878","article-title":"Priming of microglia with IFN-\u03b3 impairs adult hippocampal neurogenesis and leads to depression-like behaviors and cognitive defects","volume":"68","author":"Zhang","year":"2020","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2023.109511_bib43","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.psyneuen.2016.11.036","article-title":"Cortisol stress reactivity across psychiatric disorders: a systematic review and meta-analysis","volume":"77","author":"Zorn","year":"2017","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2023.109511_bib44","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.pnpbp.2010.04.011","article-title":"Glucocorticoids, cytokines and brain abnormalities in depression","volume":"35","author":"Zunszain","year":"2011","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390823001016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390823001016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:24:14Z","timestamp":1758439454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390823001016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":45,"alternative-id":["S0028390823001016"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109511","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"KNT-127, a selective delta opioid receptor agonist, shows beneficial effects in the hippocampal dentate gyrus of a chronic vicarious social defeat stress mouse model","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109511","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109511"}}